PDL BIOPHARMA, INC. Human Resources Contracts & Agreements

40 Contracts & Agreements

Browse by Subcategory

Bonus & Incentive Agreements (24 contracts)
Compensation Agreements (1)
Consulting Agreements (1)
Retention Agreements (1)
Separation Agreements (5)
Severance Agreements (6)
Transition Agreements (2)

Recent Contracts

Transition Services Agreement, dated as of September 30, 2020, between PDL BioPharma, Inc. and LENSAR, Inc (Filed With SEC on October 2, 2020)
Separation and Distribution Agreement, dated as of September 30, 2020, by and between PDL BioPharma, Inc (Filed With SEC on October 2, 2020)
Confidential Severance Agreement and Release of All Claims (Filed With SEC on August 20, 2020)
2020 Annual Bonus Plan (Filed With SEC on May 11, 2020)
Wind Down Retention Plan effective as of December 21, 2019 (Filed With SEC on March 11, 2020)
Severance Plan adopted as of November 15, 2019 (Filed With SEC on March 11, 2020)
Confidential Severance Agreement and Release of All Claims (Filed With SEC on August 19, 2019)
2019 Annual Bonus Plan (Filed With SEC on May 9, 2019)
Executive Severance Plan and Schedule of Benefits (Filed With SEC on April 10, 2019)
2018 Annual Bonus Plan (Filed With SEC on August 9, 2018)
Confidential Separation Agreement and Release of All Claims between Danny Hart and the Company, dated as of October 23, 2017 (Filed With SEC on November 13, 2017)
2017/21 Long-Term Incentive Plan (Filed With SEC on May 3, 2017)
2017 Annual Bonus Plan (Filed With SEC on May 3, 2017)
PDL BIOPHARMA, INC. Amended and Restated 2016/20 Long-Term Incentive Plan (Filed With SEC on May 4, 2016)
PDL BIOPHARMA, INC. 2016 Annual Bonus Plan (Filed With SEC on May 4, 2016)
PDL BIOPHARMA, INC. Amended and Restated 2015/19 Long-Term Incentive Plan (Filed With SEC on November 4, 2015)
PDL BIOPHARMA, INC. Amended and Restated 2015 Annual Bonus Plan (Filed With SEC on November 4, 2015)
PDL BIOPHARMA, INC. AMENDED AND RESTATED 2005 EQUITY INCENTIVE PLAN ORIGINALLY EFFECTIVE: JUNE 8, 2005 AMENDED EFFECTIVE: JUNE 20, 2007 AND JUNE 4, 2009 AMENDMENT AND RESTATEMENT... (Filed With SEC on August 5, 2015)
PDL BIOPHARMA, INC. 2015/19 Long-Term Incentive Plan (Filed With SEC on May 6, 2015)
PDL BIOPHARMA, INC. 2015 Annual Bonus Plan (Filed With SEC on May 6, 2015)
PDL BIOPHARMA, INC. 2014/18 Long-Term Incentive Plan (Filed With SEC on August 18, 2014)
PDL BIOPHARMA, INC. 2014 Annual Bonus Plan (Filed With SEC on May 12, 2014)
PDL BIOPHARMA, INC. 2014 Long-Term Incentive Plan (Filed With SEC on May 9, 2013)
PDL BIOPHARMA, INC. 2013 Annual Bonus Plan (Filed With SEC on May 9, 2013)
PDLBIOPHARMA, INC. 2012 Annual Bonus Plan (Filed With SEC on February 23, 2012)
PDL BIOPHARMA, INC. 2013 Long-Term Incentive Plan (Filed With SEC on February 23, 2012)
2012 Long-Term Incentive Plan (Filed With SEC on July 29, 2011)
Form of Executive Officer Severance Agreement (Filed With SEC on May 26, 2011)
PDLBIOPHARMA,INC. 2011Annual Bonus Plan (Filed With SEC on January 26, 2011)
PDL BIOPHARMA, INC. 2010 Annual Bonus Plan (Filed With SEC on April 19, 2010)
AMENDMENT NO. 1 TO SEPARATION AND DISTRIBUTION AGREEMENT (Filed With SEC on March 2, 2009)
Transition Services Agreement PDL BioPharma, Inc., a Delaware corporation and Facet Biotech Corporation, a Delaware corporation Dated as of December 18, 2008 (Filed With SEC on December 23, 2008)
Separation and Distribution Agreement between PDLBioPharma, Inc., a Delawarecorporation and FacetBiotech Corporation, a Delawarecorporation Dated as of December17, 2008 (Filed With SEC on December 23, 2008)
CONFIDENTIAL SEPARATION AGREEMENTAND GENERAL RELEASE (Filed With SEC on November 7, 2008)
PDLBIOPHARMA, INC. RETENTIONAND SEVERANCE PLAN FOR CHIEFEXECUTIVE OFFICER (Filed With SEC on September 25, 2008)
PDL BioPharma, Inc. 2005 Equity Incentive Plan (Filed With SEC on June 22, 2007)
PDL BioPharma, Inc. 2005 Equity Incentive Plan (Filed With SEC on May 10, 2007)
PDL BIOPHARMA, INC. STOCK OPTION AGREEMENT (INCENTIVE) (Filed With SEC on August 9, 2006)
AMENDED AND RESTATED CONSULTING AGREEMENT (Filed With SEC on March 16, 2006)
AMENDMENT NO. 1 TO SPECIAL COMPENSATION AND EMPLOYMENT AGREEMENT DATED MAY 1, 2002 BETWEEN LAURENCE JAY KORN AND PROTEIN DESIGNLABS, INC. (Filed With SEC on May 5, 2004)